Another study using rodent model of cerebral ischemia demonstrated that class IIA HDAC inhibitor TMP269 treatment protected BBB by increasing expression of the tight-junction proteins in endothelial cells (Su et al., 2020). The gene discussed is HDAC9; the disease is brain ischemia.